SCHEMBL237755

SCHEMBL237755

CO[C@]1(C)[C@H](O)[C@@H](CO)O[C@@]1(C)n1cnc2c(=O)[nH]c(N)nc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.46
PNP P00491 3/20 0.44
BLM P54132 2/20 0.44
USP2 O75604 1/20 0.44
TSHR P16473 1/20 0.44
EDNRA P25101 1/20 0.44
HTR2A P28223 1/20 0.44
RECQL P46063 1/20 0.44
HBB P68871 1/20 0.44
HSD17B10 Q99714 1/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
ALDH1A1 P00352 1/20 0.43
LMNA P02545 1/20 0.43
CYP3A4 P08684 1/20 0.43
NFKB1 P19838 1/20 0.43
VCP P55072 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
HIF1A Q16665 1/20 0.43
TK1 P04183 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1964956 0.87 TK1 (0.46) HPGDPNPBLMUSP2TSHR
SCHEMBL14782967 0.82 HPGD (0.46) HPGDPNPBLMUSP2TSHR
SCHEMBL28237443 0.81 HPGD (0.46) HPGDPNPBLMUSP2TSHR
SCHEMBL28260991 0.81 TK1 (0.44) HPGDPNPBLMUSP2TSHR
SCHEMBL13626438 0.81 ADORA3 (0.47) HPGDPNPBLMUSP2TSHR
SCHEMBL18537395 0.81 ADORA3 (0.47) HPGDPNPBLMUSP2TSHR
SCHEMBL18537401 0.81 ADORA3 (0.47) HPGDPNPBLMUSP2TSHR
SCHEMBL14620703 0.81 ADORA3 (0.47) HPGDPNPBLMUSP2TSHR
SCHEMBL116166 0.81 ADORA3 (0.47) HPGDPNPBLMUSP2TSHR
SCHEMBL16258667 0.81 ADORA3 (0.47) HPGDPNPBLMUSP2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 278 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025038853-A1 USHER SYNDROME-RELATED GENE MODIFICATION AMBER BIO INC. (US) 2025-02-20 WO claimed
EP-4379052-A2 MRNA PURIFICATION BY TANGENTIAL FLOW FILTRATION Ethris GmbH (DE) 2024-06-05 EP claimed
EP-4306643-A2 PLASMID CONTAINING A SEQUENCE ENCODING AN MRNA WITH A SEGMENTED POLY(A) TAIL ethris GmbH (DE) 2024-01-17 EP claimed
EP-1027432-A2 RIBOZYMES TARGETED TO IL-15 mRNA Hisamitsu Pharmaceutical Co., Inc. (JP) 2000-08-16 EP claimed
US-6087172-A FOR TREATMENT OF RHEUMATOID ARTHRITIS BY SUPPRESSION OF INTERLEUKIN-15 PRODUCTION HISAMITSU PHARMACEUTICAL CO., INC. (JP) 2000-07-11 US claimed
EP-0948513-A1 DELIVERY CONSTRUCT FOR ANTISENSE NUCLEIC ACIDS AND METHODS OF USE THE JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE (US) 1999-10-13 EP claimed
US-5942395-A A RECOMBINANT RNA HAVING A HAMMERHEAD OR HAIRPIN RIBOZYME CATALYTIC SEQUENCE AND A SMALL NUCLEOLAR RNA STABILIZING MOTIF; ANTICARCINOGENIC/ANTITUMOR/ANTIPROTOZOA AGENTS, TREATMENT OF HIV, AUTOIMMUNE AND CARDIOVASCULAR DISEASES UNIVERSITE DE MONTREAL (CA) 1999-08-24 US claimed
WO-1999023208-A2 RIBOZYMES TARGETED TO IL-15 mRNA HISAMITSU PHARMACEUTICAL CO., INC. (JP) 1999-05-14 WO claimed
WO-1998050408-A1 HYBRID RIBOZYMES AND METHODS OF USE UNIVERSITY OF MASSACHUSETTS (US) 1998-11-12 WO claimed
US-5814500-A FOR SUPPRESSING EXPRESSION OF A TARGET GENE THE JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE (US) 1998-09-29 US claimed
WO-1998018811-A1 DELIVERY CONSTRUCT FOR ANTISENSE NUCLEIC ACIDS AND METHODS OF USE THE JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE (US) 1998-05-07 WO claimed
CN-113396219-B Purification of mRNA by tangential flow filtration ETHRIS GMBH (DE) 2026-05-26 CN disclosed
EP-4276189-B1 INITIATING CAPPED OLIGONUCLEOTIDE PRIMERS FOR SYNTHESIZING 5'-CAPPED RNAS TRILINK BIOTECHNOLOGIES LLC (US) 2026-04-01 EP disclosed
EP-4717779-A2 COMPOSITIONS AND METHODS FOR SYNTHESIZING 5'-CAPPED RNAS TriLink BioTechnologies, LLC (US) 2026-04-01 EP disclosed
CN-121586722-A Compositions and methods for generating immunity to bacterial infections 辛泰伦有限责任公司 2026-02-27 CN disclosed
WO-1998045450-A1 PURIFIED TELOMERASE GERON CORPORATION (US) 1998-10-15 WO disclosed
US-5814500-A FOR SUPPRESSING EXPRESSION OF A TARGET GENE THE JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE (US) 1998-09-29 US disclosed
WO-1998039661-A1 METHOD FOR IDENTIFYING HORMONALLY MODULATED GENES DIAGNOSTIC PRODUCTS CORPORATION (US) 1998-09-11 WO disclosed
WO-1998018811-A1 DELIVERY CONSTRUCT FOR ANTISENSE NUCLEIC ACIDS AND METHODS OF USE THE JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE (US) 1998-05-07 WO disclosed
EP-0311694-A1 NUCLEOSIDE DERIVATIVES AND PROCESS FOR THEIR PREPARATION RIKAGAKU KENKYUSHO (JP) 1989-04-19 EP disclosed